Amy Werremeyer

747 total citations
46 papers, 526 citations indexed

About

Amy Werremeyer is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and General Health Professions. According to data from OpenAlex, Amy Werremeyer has authored 46 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 17 papers in Geriatrics and Gerontology and 12 papers in General Health Professions. Recurrent topics in Amy Werremeyer's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Opioid Use Disorder Treatment (16 papers) and Mental Health Treatment and Access (9 papers). Amy Werremeyer is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Opioid Use Disorder Treatment (16 papers) and Mental Health Treatment and Access (9 papers). Amy Werremeyer collaborates with scholars based in United States and Denmark. Amy Werremeyer's co-authors include Elizabeth Skoy, Heidi Eukel, Mark Strand, Jeanne E. Frenzel, Lisa W. Goldstone, Natasha Petry, Jolene R. Bostwick, Cristofer Price, Jerry McKee and Shannon N. Saldaña and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychiatric Services and Qualitative Health Research.

In The Last Decade

Amy Werremeyer

43 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Werremeyer United States 15 226 222 139 103 87 46 526
Elizabeth Skoy United States 14 191 0.8× 291 1.3× 157 1.1× 47 0.5× 66 0.8× 46 522
Priscilla T. Ryder United States 13 119 0.5× 155 0.7× 120 0.9× 99 1.0× 21 0.2× 18 531
Arnie Aldridge United States 17 133 0.6× 259 1.2× 259 1.9× 58 0.6× 53 0.6× 51 816
Safeera Hussainy Australia 15 150 0.7× 390 1.8× 154 1.1× 73 0.7× 14 0.2× 55 706
Laura Palombi United States 14 129 0.6× 250 1.1× 159 1.1× 12 0.1× 42 0.5× 42 454
Christopher W. Shanahan United States 14 76 0.3× 360 1.6× 123 0.9× 78 0.8× 33 0.4× 28 582
Alicia A. Bergman United States 13 63 0.3× 240 1.1× 219 1.6× 34 0.3× 23 0.3× 28 548
Zachary Smothers United States 11 86 0.4× 222 1.0× 110 0.8× 12 0.1× 46 0.5× 13 368
Amanda Slaunwhite Canada 19 45 0.2× 639 2.9× 193 1.4× 51 0.5× 104 1.2× 74 980
Corinne Schalm Canada 11 96 0.4× 85 0.4× 375 2.7× 115 1.1× 18 0.2× 16 486

Countries citing papers authored by Amy Werremeyer

Since Specialization
Citations

This map shows the geographic impact of Amy Werremeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Werremeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Werremeyer more than expected).

Fields of papers citing papers by Amy Werremeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Werremeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Werremeyer. The network helps show where Amy Werremeyer may publish in the future.

Co-authorship network of co-authors of Amy Werremeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Werremeyer. A scholar is included among the top collaborators of Amy Werremeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Werremeyer. Amy Werremeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skoy, Elizabeth, et al.. (2025). Creation of the CAP center: Advancing pharmacy practice through implementation science integration. Journal of the American Pharmacists Association. 66(1). 102961–102961.
2.
LONG, A., et al.. (2023). Pharmacy and nursing students' stigma and perceptions toward individuals with mental illness impacted through interaction with a website featuring lived experiences. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(2). 123–132. 1 indexed citations
3.
Dopheide, Julie A., et al.. (2022). Positioning psychiatric pharmacists to improve mental health care. Mental Health Clinician. 12(2). 77–85. 14 indexed citations
4.
Strand, Mark, et al.. (2022). Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk Tool. Research in Social and Administrative Pharmacy. 18(12). 4065–4071. 4 indexed citations
6.
Werremeyer, Amy, et al.. (2022). Impact of an Emergency Department Simulation on Pharmacy Students’ Interprofessional Team Skills and Attitudes. INNOVATIONS in pharmacy. 13(4). 1–1. 3 indexed citations
8.
Eukel, Heidi, et al.. (2021). Opioid risk screening: Program evaluation from the community pharmacists’ perspective. Journal of the American Pharmacists Association. 62(3). 859–863.e1. 5 indexed citations
9.
Werremeyer, Amy, et al.. (2021). Pharmacists’ Stigma Toward Patients Engaged in Opioid Misuse: When “Social Distance” does not Mean Disease Prevention. Substance Abuse. 42(4). 919–926. 31 indexed citations
10.
Harris, Suzanne C., Jolene R. Bostwick, Amy Werremeyer, et al.. (2021). Addressing the Conflict Between Promoting Wellness, Perpetuating Mental Illness Stigma and Making Psychiatric Pharmacy Education Less Intense. American Journal of Pharmaceutical Education. 85(7). 8354–8354. 4 indexed citations
11.
Arévalo, Lourdes Cantarero & Amy Werremeyer. (2021). Community involvement and awareness raising for better development, access and use of medicines: The transformative potential of photovoice. Research in Social and Administrative Pharmacy. 17(12). 2062–2069. 8 indexed citations
12.
Werremeyer, Amy, et al.. (2020). Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Mental Health Clinician. 10(6). 358–380. 35 indexed citations
13.
Werremeyer, Amy, et al.. (2020). Photovoice as an intervention for college students living with mental illness: A pilot study. Mental Health Clinician. 10(4). 237–243. 17 indexed citations
14.
Eukel, Heidi, et al.. (2020). Opioid Misuse and Overdose: Changes in Pharmacist Practices and Outcomes. Journal of Continuing Education in the Health Professions. 40(4). 242–247. 12 indexed citations
15.
Eukel, Heidi, et al.. (2020). Examining Attitudes and Beliefs that Inhibit Pharmacist Implementation of a Statewide Opioid Harm Reduction Program. SHILAP Revista de lepidopterología. 11(4). 8–8. 6 indexed citations
16.
Eukel, Heidi, et al.. (2019). Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention. Journal of Continuing Education in the Health Professions. 39(1). 7–12. 34 indexed citations
17.
Strand, Mark, et al.. (2019). Program evaluation of the Opioid and Naloxone Education (ONE Rx) program using the RE-AIM model. Research in Social and Administrative Pharmacy. 16(9). 1248–1254. 23 indexed citations
18.
Werremeyer, Amy & Elizabeth Skoy. (2012). A Medical Mission to Guatemala as an Advanced Pharmacy Practice Experience. American Journal of Pharmaceutical Education. 76(8). 156–156. 35 indexed citations
19.
Werremeyer, Amy, et al.. (2011). Poster Project to Emphasize Public Health in the Pharmacy Curriculum. American Journal of Pharmaceutical Education. 75(1). 2–2. 22 indexed citations
20.
Werremeyer, Amy, et al.. (2010). Current Events Project in a Pharmacotherapy Course. American Journal of Pharmaceutical Education. 74(4). 58–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026